Pfizer Inc. (NYSE:PFE) is among the 14 Best Pharma Dividend Stocks to Buy in 2025. Despite recent stock declines, Pfizer’s strong drug pipeline and low forward P/E ratio of 8.3 suggest a brighter future. In the first quarter of 2025, Pfizer reported revenue of $13.7 billion, down 8% YoY, but beat EPS estimates. The company’s emphasis on efficiency and financial discipline is positively impacting its bottom line. Pfizer’s strong balance sheet allowed it to return $2.4 billion to shareholders through dividends. With a 15-year history of dividend increases, Pfizer offers a quarterly dividend of $0.43 per share with a yield of 7.03%.

Read more at Yahoo Finance: Balancing Innovation and Shareholder Returns